- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT04190030
Virginia Commonwealth University Stress Reduction Study
2 augustus 2022 bijgewerkt door: Virginia Commonwealth University
This research study seeks to understand how stress reduction training influences neural responses (brain activation) and behavior related to stress, including emotions and reactions to social conflict.
Studie Overzicht
Toestand
Voltooid
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
The full research project will be conducted over approximately 2-3 weeks, and will consist of two data collection sessions, one before and one after a 14-day stress reduction training course conducted via a smartphone that participants provide.
This course entails instructor-facilitated stress reduction exercises previously shown to reduce stress and improve well-being.
Participants will be randomly assigned to a mindfulness course or a cognitive reappraisal course.
Both of these courses -mindfulness training (MT) and cognitive reappraisal training (RT) - involve expert-facilitated mental wellness techniques.
MT emphasizes mindfulness-based techniques to reduce stress and promote wellbeing, whereas CT emphasizes reframing and reappraisal techniques to reduce stress and promote well-being.
Studietype
Ingrijpend
Inschrijving (Werkelijk)
72
Fase
- Niet toepasbaar
Contacten en locaties
In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.
Studie Locaties
-
-
Virginia
-
Richmond, Virginia, Verenigde Staten, 23298
- Virginia Commonwealth University
-
-
Deelname Criteria
Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
18 jaar tot 88 jaar (Volwassen, Oudere volwassene)
Accepteert gezonde vrijwilligers
Ja
Geslachten die in aanmerking komen voor studie
Allemaal
Beschrijving
Inclusion Criteria:
- Stable medication regiment for 8 weeks prior to enrollment if taking antidepressant or anxiolytic medications. (will not be advertised but screened)
- Free of major, uncorrected sensory impairments and cognitive deficits
- Free of a certain psychiatric disorders or history thereof; specifically, a new diagnosis of a (non-acute) medical or psychiatric condition within the last 3 months, report a hospitalization over the last 3 months, report current drug abuse (e.g., recreational drug use, alcohol intake in excess of 2 drinks per day).
- Adults aged 18 - 55 years of age
- Right hand dominant (will not be advertised but screened)
- Personal SmartPhone (Android or iOS operating systems).
- Naive to meditation practice (will not be advertised but screened)
- At least a moderate level of perceived stress (scale score > 5 on the 4-item Perceived Stress Scale (PSS; reflects above-average perceived stress)
Exclusion Criteria:
- left-handed
- are unwilling or unable to complete study assessments or treatments
- report a new diagnosis of a (non-acute) medical or psychiatric condition within the last 3 months
- report a hospitalization over the last 3 months
- report current drug abuse (e.g., recreational drug use, smoke more than � pack per day, alcohol intake in excess of 2 drinks per day)
- are prisoners
- no personal SmartPhone (Android or iOS operating systems)
Studie plan
Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Fundamentele wetenschap
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Dubbele
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Mindfulness
|
Participants will listen to 20-minute lessons each day for 14 days plus complete brief (3 to 10 minute) exercises daily via their personal smartphone.
Each course will involve mental exercises to reduce stress in daily life, along with direct instruction from the course leader to help in learning and applying the stress reduction techniques.
|
|
Actieve vergelijker: Cognitive reappraisal
|
Participants will listen to 20-minute lessons each day for 14 days plus complete brief (3 to 10 minute) exercises daily via their personal smartphone.
Each course will involve mental exercises to reduce stress in daily life, along with direct instruction from the course leader to help in learning and applying the stress reduction techniques.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Functional near-infrared spectroscopy (fNIRS) hemodynamic signal change
Tijdsspanne: Baseline and 16 weeks
|
Proportion of participants who show a statistically significant change in regional specificity, as measured by fNIRS-recorded blood oxygenation representing markers of emotion reactivity and regulation during observation of video stimuli.
|
Baseline and 16 weeks
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Change in anger response
Tijdsspanne: Baseline and 16 weeks
|
The Anger subscale of the Discrete Emotions Questionnaire (DEQ) will be used to assess s the extent to which participants experience specific emotions on a scale from 1 (not at all) to 7 (an extreme amount) in response to video stimuli.
Lower scores indicate less anger and more emotion downregulation.
Higher scores would indicate more anger and less emotion downregulation.
|
Baseline and 16 weeks
|
|
Change in disgust response
Tijdsspanne: Baseline and 16 weeks
|
The Disgust subscale of the Discrete Emotions Questionnaire (DEQ) will be used to assess the extent to which participants experience specific emotions on a scale from 1 (not at all) to 7 (an extreme amount) in response to video stimuli.
Lower scores indicate less disgust and more emotion downregulation.
Higher scores would indicate more disgust and less emotion downregulation.
|
Baseline and 16 weeks
|
|
Change in fear response
Tijdsspanne: Baseline and 16 weeks
|
The Fear subscale of the Discrete Emotions Questionnaire (DEQ) will be used to assess the extent to which participants experience specific emotions on a scale from 1 (not at all) to 7 (an extreme amount) in response to video stimuli.
Lower scores indicate less fear and more emotion downregulation.
Higher scores would indicate more fear and less emotion downregulation.
|
Baseline and 16 weeks
|
|
Change in anxiety response
Tijdsspanne: Baseline and 16 weeks
|
The Anxiety subscale of the Discrete Emotions Questionnaire (DEQ) will be used to assess the extent to which participants experience specific emotions on a scale from 1 (not at all) to 7 (an extreme amount) in response to video stimuli.
Lower scores indicate less anxiety and more emotion downregulation.
Higher scores would indicate more anxiety and less emotion downregulation.
|
Baseline and 16 weeks
|
|
Change in sadness response
Tijdsspanne: Baseline and 16 weeks
|
The Sadness subscale of the Discrete Emotions Questionnaire (DEQ) will be used to assess the extent to which participants experience specific emotions on a scale from 1 (not at all) to 7 (an extreme amount) in response to video stimuli.
Lower scores indicate less sadness and more emotion downregulation.
Higher scores would indicate more sadness and less emotion downregulation.
|
Baseline and 16 weeks
|
|
Change in intergroup attitudes
Tijdsspanne: Baseline and 16 weeks
|
The Beliefs about Groups survey will be used to assess explicit intergroup attitudes.
Participants answer 4 questions using a scale from 1 to 6. Higher scores indicate poorer attitude outcomes.
|
Baseline and 16 weeks
|
|
Behavioral willingness to participate in a dyad-based future experiment
Tijdsspanne: 16 weeks
|
Number of participants who express willingness to participate in a dyad-based future experiment using a scale from 1 to 5. Higher scores indicate greater willingness or preference to participate.
|
16 weeks
|
Medewerkers en onderzoekers
Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.
Sponsor
Medewerkers
Onderzoekers
- Hoofdonderzoeker: Hadley Rahrig, M.S., Virginia Commonwealth University
Studie record data
Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.
Bestudeer belangrijke data
Studie start (Werkelijk)
19 juli 2021
Primaire voltooiing (Werkelijk)
31 juli 2022
Studie voltooiing (Werkelijk)
31 juli 2022
Studieregistratiedata
Eerst ingediend
4 december 2019
Eerst ingediend dat voldeed aan de QC-criteria
4 december 2019
Eerst geplaatst (Werkelijk)
9 december 2019
Updates van studierecords
Laatste update geplaatst (Werkelijk)
3 augustus 2022
Laatste update ingediend die voldeed aan QC-criteria
2 augustus 2022
Laatst geverifieerd
1 augustus 2022
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Andere studie-ID-nummers
- HM20015897
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
NEE
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Nee
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Nee
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .